AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
216 hedge funds and large institutions have $2.6B invested in Amedisys in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 63 increasing their positions, 78 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 194 → 216 (+22)
7.76% less ownership
Funds ownership: 97.24% → 89.48% (-7.8%)
19% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 78
Holders
216
Holding in Top 10
2
Calls
$12.8M
Puts
$6.84M
Top Buyers
| 1 | +$125M | |
| 2 | +$32.2M | |
| 3 | +$26.8M | |
| 4 |
JP Morgan Chase
New York
|
+$17.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$17.1M |
Top Sellers
| 1 | -$207M | |
| 2 | -$53.8M | |
| 3 | -$33.5M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$25.8M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$25.1M |